Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 172

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 19
Chunk 172
---
 going concern basis of accounting unless the Directors either intend to liquidate the Group or to cease operations, or have
no realistic alternative but to do so.

Auditor’s responsibilities for the audit of
the financial report

Our objectives are to obtain reasonable assurance about
whether the financial report as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s
report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in
accordance with the Australian Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic
decisions of users taken on the basis of this financial report.

A further description of our responsibilities for the audit
of the financial report is located at the Auditing and Assurance Standards Board website at: http://www. auasb. gov. au/media/bwvjcgre/ar1_2024. pdf.
This description forms part of our auditor’s report.

Report on the remuneration report

Opinion on the remuneration report

We have audited the Remuneration Report included in pages 54 to 63 of the Directors’ report for
the year ended 30 June 2025.

In our opinion, the Remuneration Report of Radiopharm
Theranostics Limited, for the year ended 30 June 2025 complies with section 300A of the Corporations Act 2001.

Responsibilities

The Directors of the Company are responsible
for the preparation and presentation of the Remuneration Report in accordance with section 300A of theCorporations Act 2001. Our
responsibility is to express an opinion on the Remuneration Report, based on our audit conducted in accordance with Australian Auditing
Standards.

  /s/ Grant Thornton Audit Pty Ltd  
  Grant Thornton Audit Pty Ltd      
  Chartered Accountants             
  /s/ M A Cunningham                
  M A Cunningham                    
  Partner – Audit & Assurance       
  Melbourne, 16 September 2025      

Grant Thornton Audit Pty Ltd

CORPORATE GOVERNANCE

Radiopharm Theranostics Limited and its Board of Directors are committed
to implementing and achieving an effective corporate governance framework. Our Corporate Governance Statement can be found on our website
at www. radiopharmther